MindMed: Funding, Investors & Team (Sep 2026)
MindMed offers treatments and therapies for substance abuse disorders and mental illnesses that are inspired by psychedelics. The company is developing a range of innovative drugs based on substances like Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative called 18-MC.
MindMed has raised $265M across 3 funding rounds on record, the most recent an undisclosed round of $75.0M announced in Aug 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
MindMed Company Profile and Key Stats
Latest funding round on record: Aug 2024.
MindMed Funding Rounds
MindMed raised $15.0M in an undisclosed round announced in Aug 2023.
7 months later, an undisclosed round of $175M was announced in Mar 2024.
5 months later, an undisclosed round of $75.0M was announced in Aug 2024.
MindMed Founders and Leadership Team
Contact details for the MindMed team: 1 of 2 have an email address on file.
Start 14-day free trial →MindMed Funding Compared to Other Biotechnology Startups
MindMed's latest round of $75.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MindMed in Biotechnology and New York
Companies Similar to MindMed
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
MindMed Funding FAQs
What does MindMed do?
MindMed offers treatments and therapies for substance abuse disorders and mental illnesses that are inspired by psychedelics. The company is developing a range of innovative drugs based on substances like Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative called 18-MC.
How much funding has MindMed raised?
MindMed has raised $265M across 3 rounds on record. The most recent is an undisclosed round of $75.0M announced in Aug 2024.
When did MindMed last raise funding?
MindMed's most recent funding round on record is an undisclosed round of $75.0M, announced in Aug 2024.
Who founded MindMed?
FundedIQ lists Leonard Latchman (Founder), Robert Barrow (Founder) at MindMed.
Where is MindMed headquartered?
MindMed is based in New York, United States.
How many employees does MindMed have?
MindMed is in the 101-250 employee band.
How does MindMed's funding compare to other Biotechnology startups?
MindMed's latest round of $75.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's MindMed Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MindMed is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.